STSS vs NNBR vs MMSI vs NXRT vs SRTS

For growth investors, Merit Medical Systems, Inc.

(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus -34. 3% for Sensus Healthcare, Inc. (SRTS). Merit Medical Systems, Inc. (MMSI) offers the better valuation at 29. 3x trailing P/E (15. 5x forward), making it the more compelling value choice. Analysts rate NN, Inc. (NNBR) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Merit Medical Systems, Inc.

is actually cheaper at 15. 5x.

Over the past 5 years, Sensus Healthcare, Inc.

(SRTS) delivered a total return of +20. 9%, compared to -100. 0% for Sharps Technology, Inc. (STSS). Over 10 years, the gap is even starker: MMSI returned +214. 6% versus STSS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), NexPoint Residential Trust, Inc.

(NXRT) is the lower-risk stock at 0. 62β versus Sharps Technology, Inc. 's 2. 56β — meaning STSS is approximately 310% more volatile than NXRT relative to the S&P 500. On balance sheet safety, Sensus Healthcare, Inc. (SRTS) carries a lower debt/equity ratio of 1% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Merit Medical Systems, Inc.

(MMSI) is pulling ahead at 11. 7% versus -34. 3% for Sensus Healthcare, Inc. (SRTS). On earnings-per-share growth, the picture is similar: Merit Medical Systems, Inc. grew EPS 4. 9% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Merit Medical Systems, Inc.

(MMSI) is the more profitable company, earning 8. 5% net margin versus -324. 8% for Sharps Technology, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMSI leads at 12. 2% versus -40. 9% for STSS. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Merit Medical Systems, Inc.

(MMSI) trades at 15. 5x forward P/E versus 43. 6x for NN, Inc. — 28. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMSI: 52. 4% to $95. 00.

In this comparison, NXRT (7.

1% yield) pays a dividend. STSS, NNBR, MMSI, SRTS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, NexPoint Residential Trust, Inc.

(NXRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 62), 7. 1% yield, +211. 1% 10Y return). Sharps Technology, Inc. (STSS) carries a higher beta of 2. 56 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NXRT: +211. 1%, STSS: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (STSS (Healthcare) and NNBR (Industrials) and MMSI (Healthcare) and NXRT (Real Estate) and SRTS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: STSS is a small-cap quality compounder stock; NNBR is a small-cap quality compounder stock; MMSI is a small-cap quality compounder stock; NXRT is a small-cap income-oriented stock; SRTS is a small-cap quality compounder stock. NXRT pays a dividend while STSS, NNBR, MMSI, SRTS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.